Somewhat Favorable News Coverage Somewhat Unlikely to Impact Transenterix (TRXC) Stock Price

Press coverage about Transenterix (NYSE:TRXC) has been trending somewhat positive on Friday, according to Accern. Accern rates the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Transenterix earned a news sentiment score of 0.11 on Accern’s scale. Accern also assigned media headlines about the medical instruments supplier an impact score of 45.2271602803528 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

Transenterix (TRXC) opened at 1.47 on Friday. The company has a 50-day moving average of $1.25 and a 200 day moving average of $0.87. Transenterix has a one year low of $0.45 and a one year high of $2.19. The firm’s market capitalization is $218.35 million.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2017/10/13/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-transenterix-trxc-stock-price.html.

About Transenterix

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Insider Buying and Selling by Quarter for Transenterix (NYSE:TRXC)

Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply